Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening
Year: 2019
Type: article
Source: JAMA Neurology
Institutions: University of Wisconsin–Madison, University of Rochester Medicine, University of Rochester, University of Florida, Washington University in St. Louis, Muscular Dystrophy Association, SUNY Upstate Medical University, Harvard University, Massachusetts General Hospital, American College of Medical Genetics, University of Miami
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2945658923